This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Non-small cell lung cancer, squamous, helper endpoint
HLP_C3_NSCLC_SQUAM
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
2054 |
4. Check minimum number of eventsNone |
2054 |
5. Include endpointsNone |
2054 |
6. Filter based on genotype QC (FinnGen only) |
1990 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Non-small cell lung cancer, squamous, helper endpoint
based on the number of shared cases.
Similar with more cases:
- Non-small cell lung cancer, squamous
- Non-small cell lung cancer
- Non-small cell lung cancer, including Hilmo
- Malignant neoplasm of bronchus and lung
- Malignant neoplasm of respiratory system and intrathoracic organs
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1990 | 302 | 1688 |
| Unadjusted period prevalence (%) | 0.67 | 0.11 | 0.77 |
| Median age at first event (years) | 71.95 | 70.39 | 72.23 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2054
- Matched controls
- 20540
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
12.2
307.7
1054
1636
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
20.9
307.7
676
472
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
307.7
501
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
307.7
416
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
22.6
307.7
244
122
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
307.7
1028
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
23.4
307.7
290
143
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
255.6
307.7
759
47
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
30.2
307.7
423
175
UGC12
NOMESCO Finland
Flexible bronchoscopy
14.2
307.7
967
1211
L01CA04
ATC
vinorelbine; systemic
45.2
307.7
226
56
GDC00
NOMESCO Finland
Lobectomy of lung
65.5
307.7
238
41
130
Kela drug reimbursment
Malignant tumour
11.8
307.7
940
1370
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
279.6
307.7
582
29
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
197.2
307.7
228
13
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
29.8
307.7
583
270
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
132.8
294.0
148
12
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
30.6
288.3
192
69
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
105.5
285.3
147
15
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
25.7
273.7
194
83
H02AB02
ATC
dexamethasone; systemic
6.0
249.9
534
1133
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
12.8
230.4
234
205
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.3
212.2
814
2743
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
22.7
208.0
154
73
WF004
NOMESCO Finland
Palliative radiotherapy
11.5
200.9
217
208
A03FA01
ATC
metoclopramide; systemic, rectal
4.1
191.6
748
2525
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
14.6
190.6
176
131
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
12.7
181.9
183
157
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
19.2
172.4
137
76
1623A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]
48.4
166.2
97
21
R84
ICPC
Malignant neoplasm bronchus/lung
35.3
164.5
104
31
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
10.0
152.5
181
197
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.4
149.3
231
347
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.7
145.9
299
595
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
9.7
144.2
175
196
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
25.2
143.1
101
42
A04AA01
ATC
ondansetron; systemic, rectal
5.3
138.4
311
671
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
12.6
133.2
133
112
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
28.1
131.2
89
33
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
21.8
128.5
96
46
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
10.7
127.5
142
141
TGD00
NOMESCO Finland
Needle biopsy of lung
30.2
126.8
84
29
A04AA55
ATC
palonosetron, combinations; systemic
11.0
124.0
136
132
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
13.0
120.6
118
96
5826
FHL
Lobectomy or bilobectomy
33.8
117.3
75
23
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
19.1
117.3
93
51
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
28.5
114.2
77
28
Z51.5
ICD-10 Finland
Palliative care
3.8
112.2
407
1259
N02AA05
ATC
oxycodone; systemic
2.9
107.6
692
3020
R03BB04
ATC
tiotropium bromide; inhalant
3.2
104.8
536
2052
GD1AD
NOMESCO Finland
Thorax CT examination
4.7
103.9
261
613
WF002
NOMESCO Finland
Radical radiotherapy
4.5
99.3
269
670
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
335.8
96.8
97
*
R04.2
ICD-10 Finland
Haemoptysis
4.9
94.2
225
506
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.4
91.2
192
387
GEA00
NOMESCO Finland
Mediastinoscopy
32.0
81.5
53
17
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
22.1
78.2
58
27
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
75.3
329
1129
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
10.6
74.2
82
80
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
9.2
72.1
89
101
H02AB06
ATC
prednisolone; systemic
2.3
70.5
1130
7201
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
15.0
67.5
60
41
GDD00
NOMESCO Finland
Pneumonectomy
124.3
67.3
72
6
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.1
63.6
183
473
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
6.2
62.8
111
189
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.9
62.7
199
552
8070/3-C34.0
ICD-O-3
Squamous cell carcinoma, NOS, of main bronchus
+∞
61.8
59
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
61.5
958
5931
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
24.4
60.3
43
18
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
14.6
59.7
54
38
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.6
58.2
207
620
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
9.4
57.1
69
76
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.7
55.6
353
1475
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
13.7
54.6
51
38
N07BA03
ATC
varenicline; oral
5.4
52.6
107
208
A98
ICPC
Health maint/preventive medicine
0.5
51.0
986
13330
A04AA02
ATC
granisetron; systemic, transdermal
3.6
49.6
175
520
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.1
48.5
218
753
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
12.6
47.9
47
38
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.6
47.8
117
266
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
14.8
46.9
42
29
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.9
46.8
142
380
1625A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA EPIDERMOIDES]
76.3
46.2
52
7
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.0
44.7
131
342
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
5.8
44.2
82
146
JN4BD
NOMESCO Finland
Extensive body CT
2.5
43.3
312
1376
R03AC02
ATC
salbutamol; inhalant
1.9
43.2
995
6803
N02AA01
ATC
morphine; systemic, rectal
4.2
42.5
116
287
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
15.1
41.7
37
25
J01MA14
ATC
moxifloxacin; systemic
2.6
41.0
270
1139
8070/3-C34.2
ICD-O-3
Squamous cell carcinoma, NOS, of middle lobe, lung
+∞
40.8
39
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.6
40.2
266
1124
J01MA12
ATC
levofloxacin; systemic
2.0
39.6
535
3038
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
4.6
38.5
94
213
WZC30
NOMESCO Finland
Teaching
2.3
36.7
335
1632
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
7.3
36.5
54
76
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.1
34.5
396
2106
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
6.8
34.5
54
81
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
34.2
507
2954
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.0
32.6
94
242
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.0
32.4
93
239
1240
FHL
Bronchoscopy
4.3
32.0
85
206
ZX095
NOMESCO Finland
Combined chemoradiotherapy
10.5
31.6
35
34
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.1
31.5
89
226
Z72.0
ICD-10 Finland
Tobacco use
5.0
31.0
68
141
B02AA02
ATC
tranexamic acid; systemic
2.4
30.4
238
1081
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
5.2
30.2
63
125
XG410
NOMESCO Finland
Flow-volume spirometry
3.1
29.7
129
435
5828
FHL
Pneumectomy
50.8
29.4
35
7
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
8.4
29.2
38
46
GDC10
NOMESCO Finland
Bilobectomy of lung
67.0
29.0
33
5
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.3
28.9
112
352
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.3
27.4
230
1075
A06AH03
ATC
naloxegol; oral
5.0
27.3
59
121
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.5
26.8
66
151
SFA20
NOMESCO Finland
Two-surface restoration
0.5
26.6
324
5496
R03BB01
ATC
ipratropium bromide; inhalant
2.3
26.6
215
989
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
26.1
351
1959
N06DX01
ATC
memantine; oral
0.2
26.1
31
1654
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
25.9
582
3807
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
24.4
25.7
36
15
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
7.9
25.6
35
45
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
25.4
25.3
35
14
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
9.8
25.0
29
30
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.8
24.9
125
457
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
24.8
291
1547
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
24.8
426
6558
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.3
24.6
50
97
L03AA13
ATC
pegfilgrastim; parenteral
3.4
24.6
91
278
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
27.9
24.5
33
12
JN4AD
NOMESCO Finland
Body CT examination
2.1
24.2
244
1226
A04AD12
ATC
aprepitant; systemic
5.6
24.2
46
84
1622A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA EPIDERMOIDES]
242.7
23.7
24
*
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
23.5
518
7497
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
23.5
175
775
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.6
23.5
145
589
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
7.6
23.4
33
44
N02AX02
ATC
tramadol; systemic, rectal
1.6
23.3
872
6462
I10
ICD-10 Finland
Essential (primary) hypertension
0.6
23.2
851
10913
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
18.7
23.1
35
19
1CD01, ,
NOMESCO Finland
36.7
23.0
29
8
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
5.9
22.8
41
71
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.0
22.8
64
162
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
6.5
22.7
37
58
1628A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA EPIDERMOIDES]
232.5
22.7
23
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
22.6
432
2683
GDC20
NOMESCO Finland
Lobectomy of lung and sleeve resection of bronchus
121.4
22.6
24
*
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
22.5
423
6400
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
5.4
22.3
44
83
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.9
22.3
65
169
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
4.2
21.8
59
145
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
4.5
21.8
53
120
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
21.5
943
7209
ZX050
NOMESCO Finland
Stereotactic radiotherapy
5.8
21.5
39
68
SFA10
NOMESCO Finland
One-surface restoration
0.6
21.5
339
5401
ZX120
NOMESCO Finland
Intravenous
2.1
21.2
224
1144
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.3
20.9
81
255
P20
ICPC
Memory disturbance
0.4
20.4
108
2525
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.5
20.3
69
200
GD002
NOMESCO Finland
Radical radiotherapy of trachea, bronchi and lungs
106.1
19.6
21
*
WX250
NOMESCO Finland
Intercostal blockade
19.6
19.5
29
15
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.3
19.4
39
75
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
19.2
33
1391
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.3
19.1
60
1795
GCA05
NOMESCO Finland
Bronchoscopic laser therapy of lesion of bronchus
70.5
18.7
21
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
18.6
298
4766
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.5
18.3
183
3380
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.5
18.1
240
4057
C10AA05
ATC
atorvastatin; oral
0.6
18.0
477
6734
J86.9
ICD-10 Finland
Pyothorax without fistula
4.5
17.8
43
97
J43.9
ICD-10 Finland
Emphysema, unspecified
3.1
17.8
76
254
TGA30
NOMESCO Finland
Thoracocentesis
4.6
17.8
42
93
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
14.7
17.6
29
20
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.0
17.1
77
265
J01AA02
ATC
doxycycline; systemic
1.5
17.1
1428
12276
S18
ICPC
Laceration/cut
0.6
17.1
434
6205
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.6
17.0
32
58
K02.1
ICD-10 Finland
Caries of dentine
0.6
16.9
388
5689
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
4.0
16.8
48
123
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
6.3
16.8
28
45
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
16.7
208
3594
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
12.9
16.1
28
22
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
16.1
305
1874
WW200, ,
SPAT
0.4
16.1
98
2179
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.8
16.1
80
291
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.5
16.1
153
2886
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
15.6
15
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.2
15.6
137
650
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.2
15.5
23
1067
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
5.5
15.3
29
53
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
15.3
301
1870
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.0
15.1
67
229
G30.8
ICD-10 Finland
Other Alzheimer disease
0.1
15.1
*
493
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
45.3
15.1
18
*
K03.64
ICD-10 Finland
Dental calculus supragingival
0.4
15.0
99
2136
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.4
15.0
92
2042
XKD00
NOMESCO Finland
Uroflowmetry
0.6
15.0
228
3734
N06DA02
ATC
donepezil; oral
0.3
14.9
35
1230
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.2
14.7
58
185
A06AC01
ATC
ispaghula (psylla seeds); oral
0.5
14.7
202
3408
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
5.7
14.6
27
48
L15
ICPC
Knee symptom/complaint
0.5
14.4
107
2209
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.3
14.2
104
457
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
19.3
14.2
21
11
1BC05, ,
NOMESCO Finland
42.8
14.1
17
*
L57.0
ICD-10 Finland
Actinic keratosis
0.4
14.0
71
1707
WX600
NOMESCO Finland
Single shot through catheter
5.2
13.9
28
54
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
0.6
13.7
393
5534
SFA30
NOMESCO Finland
Three-surface restoration
0.6
13.6
263
4058
R03DA04
ATC
theophylline; systemic, rectal
1.8
13.6
226
1337
TGC00
NOMESCO Finland
Bronchial lavation
2.8
13.5
67
244
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.3
13.4
51
159
Z01.2
ICD-10 Finland
Dental examination
0.6
13.3
251
3905
SDA03
NOMESCO Finland
Periodontal treatment
0.6
13.3
195
3239
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.6
13.2
182
3079
C08CA01
ATC
amlodipine; oral
0.7
13.2
472
6364
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
4.3
13.1
33
77
R05CB01
ATC
acetylcysteine; inhalant, oral
2.8
13.1
67
248
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.5
13.1
105
2112
C10AA07
ATC
rosuvastatin; oral
0.6
13.0
224
3570
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.5
13.0
139
2541
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
11.0
13.0
24
22
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.7
13.0
530
6970
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
16.8
13.0
20
12
GAA31
NOMESCO Finland
Thoracoscopy
10.1
13.0
25
25
R95
ICPC
Chron obstructive pulmonary disease
2.4
12.9
90
388
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.5
12.8
152
2688
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
12.8
762
6009
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
9.7
12.7
25
26
8070/3-C34.8
ICD-O-3
Squamous cell carcinoma, NOS, of overlapping lesion of lung
+∞
12.5
12
*
GDC13
NOMESCO Finland
Extended lobectomy or bilobectomy of lung
+∞
12.5
12
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.8
12.4
61
221
SCA01
NOMESCO Finland
Preventive oral health care, short
0.5
12.4
106
2088
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
12.4
17
831
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.5
12.3
153
2671
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.4
12.3
80
1739
191
Kela drug reimbursment
Erlotinib
10.6
12.2
23
22
N06DA03
ATC
rivastigmine; oral, transdermal
0.2
12.2
16
805
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.6
12.2
39
109
F03
ICD-10 Finland
Unspecified dementia
0.3
12.1
28
993
EB4VA, ,
NOMESCO Finland
0.1
12.1
6
461
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.3
12.0
88
388
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.7
12.0
400
5491
H81
ICPC
Excessive ear wax
0.5
11.9
147
2575
E83.50
ICD-10 Finland
Hypercalcemia
4.1
11.9
32
79
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.4
11.8
41
121
G04CA02
ATC
tamsulosin; oral
0.7
11.8
544
7029
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.0
11.7
125
639
L82
ICD-10 Finland
Seborrhoeic keratosis
0.5
11.7
97
1933
A02BX02
ATC
sucralfate; oral
2.1
11.7
114
564
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
0.6
11.7
164
2769
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
4.8
11.7
26
55
R24
ICPC
Haemoptysis
4.8
11.7
26
55
KMAK, ,
NOMESCO Finland
0.7
11.6
350
4916
GD004
NOMESCO Finland
Palliative radiotherapy of trachea, bronchi and lungs
30.2
11.6
15
5
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
4.1
11.6
31
76
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.5
11.5
126
2292
1624A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA EPIDERMOIDES]
+∞
11.5
11
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
8.9
11.3
23
26
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
2.3
11.3
83
367
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.6
11.2
324
4595
M01AX05
ATC
glucosamine; oral
0.6
11.2
163
2725
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.1
11.2
*
339
P70
ICPC
Dementia
0.1
11.2
5
413
XG460
NOMESCO Finland
Short time oxymetry
2.6
11.1
64
252
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.3
11.0
27
928
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.2
11.0
88
403
PJD99
NOMESCO Finland
Excision of other lymph nodes
14.0
11.0
18
13
GAC00
NOMESCO Finland
Biopsy of pleura
4.8
11.0
24
50
TDA90, ,
SPAT
0.2
11.0
9
494
N02BE01
ATC
paracetamol; systemic, rectal
0.7
10.8
1228
13801
H02
ICPC
Hearing complaint
0.5
10.8
99
1909
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.2
10.8
41
128
M01AH05
ATC
etoricoxib; oral
0.7
10.8
493
6410
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
10.6
10.8
20
19
R85
ICPC
Malignant neopl respiratory other
13.0
10.6
18
14
B01AB04
ATC
dalteparin; parenteral
2.0
10.6
107
537
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
0.6
10.6
143
2444
Z2446
NOMESCO Finland
Social worker
2.0
10.6
119
621
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.3
10.6
39
120
G04CB01
ATC
finasteride; oral
0.6
10.5
234
3522
J93.8
ICD-10 Finland
Other pneumothorax
4.7
10.5
24
52
J01FA06
ATC
roxithromycin; oral
1.4
10.4
669
5297
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
3.4
10.4
37
111
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.4
10.3
67
280
J98.1
ICD-10 Finland
Pulmonary collapse
4.4
10.3
25
57
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
18.9
10.3
15
8
C10AX09
ATC
ezetimibe; oral
0.5
10.2
92
1785
DFF00
NOMESCO Finland
Pure tone audiometry
0.4
10.2
49
1209
A79
ICPC
Malignancy NOS
3.1
10.2
42
138
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.7
10.2
361
4932
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.1
10.2
100
497
UKC02
NOMESCO Finland
Cystoscopy
0.6
10.2
232
3474
SDA04
NOMESCO Finland
Demanding periodontal treatment
0.5
10.2
111
2022
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.4
10.1
36
108
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
11.3
10.1
18
16
H13
ICPC
Plugged feeling ear
0.6
10.0
168
2712
L01XE03
ATC
[U] erlotinib
10.1
10.0
19
19
L03
ICPC
Low back symptom/complaint
0.6
10.0
147
2457
1629A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA EPIDERMOIDES]
40.3
10.0
12
*
D82
ICPC
Teeth/gum disease
0.6
9.9
183
2884
5188X
ICD-9 Finland
Other diseases of lung
4.2
9.9
26
63
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
3.4
9.9
34
100
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.2
9.9
13
651
SPAT1301
SPAT
No procedures
0.7
9.9
307
4305
VALMI, ,
NOMESCO Finland
0.5
9.8
99
1850
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
9.6
9.8
19
20
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
9.6
93
460
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.4
9.6
60
1327
G04BD12
ATC
mirabegron; oral
0.5
9.6
71
1473
F01.9
ICD-10 Finland
Vascular dementia, unspecified
0.1
9.6
*
350
SDA02
NOMESCO Finland
Periodontal treatment, brief
0.6
9.6
195
3001
SPAT1053
SPAT
Memory test
0.6
9.5
169
2692
I50.9
ICD-10 Finland
Heart failure, unspecified
0.6
9.5
259
3736
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.7
9.5
417
5488
SPAT1153
SPAT
Removal of sutures
0.7
9.5
296
4153
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
12.4
9.4
16
13
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
21.8
9.3
13
6
M25.5
ICD-10 Finland
Pain in joint
0.6
9.3
167
2654
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
9.3
414
3066
D01AE16
ATC
amorolfine; topical
0.5
9.3
67
1404
D19
ICPC
Teeth/gum symptom/complaint
0.6
9.3
123
2118
G04CA01
ATC
alfuzosin; oral
0.6
9.3
185
2864
G04CB02
ATC
dutasteride; oral
0.5
9.3
102
1855
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.4
9.2
62
1335
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
0.7
9.2
458
5906
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.3
9.2
34
105
M79.6
ICD-10 Finland
Pain in limb
0.7
9.2
324
4441
J93.9
ICD-10 Finland
Pneumothorax, unspecified
4.4
9.1
22
50
R53
ICD-10 Finland
Malaise and fatigue
0.6
9.1
215
3200
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
15.6
9.0
14
9
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
15.6
9.0
14
9
N05AX08
ATC
risperidone; systemic
0.4
9.0
60
1296
WX892
NOMESCO Finland
Monitored bed care
1.7
9.0
158
949
JN6AD
NOMESCO Finland
CT of torso and neck
3.4
8.9
31
92
EB1VA, ,
NOMESCO Finland
0.3
8.9
23
765
J94.8
ICD-10 Finland
Other specified pleural conditions
2.5
8.8
56
232
SPAT1109
SPAT
Analgesia with portable analgesic pump
4.0
8.8
24
60
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
9.5
8.8
17
18
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
0.4
8.6
53
1178
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
8.6
142
2305
7866A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Swelling, mass, or lump in chest
8.2
8.6
18
22
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
8.2
8.6
18
22
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
16.3
8.5
13
8
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
8.5
457
5841
L13
ICPC
Hip symptom/complaint
0.6
8.5
113
1947
116
Kela drug reimbursment
Prostate cancer
0.5
8.5
92
1684
WX330
NOMESCO Finland
Paravertebral ansthesia
90.4
8.4
9
*
GDB20
NOMESCO Finland
Segmental resection of lung
+∞
8.3
8
*
H91.1
ICD-10 Finland
Presbycusis
0.4
8.3
56
1205
C10AA01
ATC
simvastatin; oral
0.8
8.3
704
8411
N02AC04
ATC
dextropropoxyphene; oral
1.8
8.3
119
673
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
0.5
8.3
58
1228
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
0.6
8.2
117
1979
M54.5
ICD-10 Finland
Low back pain
0.7
8.2
245
3483
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.6
8.2
108
1866
S82
ICPC
Naevus/mole
0.4
8.2
55
1184
GDA10
NOMESCO Finland
Biopsy of lung
7.6
8.2
18
24
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
4.8
8.1
18
38
R06.0
ICD-10 Finland
Dyspnoea
1.4
8.1
511
4007
JN5AP
NOMESCO Finland
Total body PET (1 picture)
33.5
8.1
10
*
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
33.5
8.1
10
*
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.7
8.1
228
3276
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.5
8.1
75
1439
N05CF01
ATC
zopiclone; oral
1.3
8.0
643
5233
DAX08
NOMESCO Finland
Fitting of hearing aid
0.3
7.9
27
779
R4110, ,
SPAT
0.3
7.9
23
719
L03AA14
ATC
lipegfilgrastim; parenteral
3.4
7.9
28
84
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
7.9
273
1925
SPAT1325
SPAT
Vaccination
0.7
7.8
386
5014
205
Kela drug reimbursment
Chronic hypertension
0.7
7.8
482
6046
N03AX16
ATC
[U] pregabalin
1.4
7.8
352
2607
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
0.6
7.8
143
2265
XJH00
NOMESCO Finland
Transanal ultrasonography
0.5
7.8
81
1501
Z51.0
ICD-10 Finland
Radiotherapy session
2.9
7.6
35
123
Z97.4
ICD-10 Finland
Presence of external hearing-aid
0.4
7.6
36
892
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
0.6
7.6
172
2593
H25.1
ICD-10 Finland
Senile nuclear cataract
0.7
7.6
470
5896
UJF32
NOMESCO Finland
Coloscopy
0.7
7.6
273
3745
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
4.1
7.5
20
49
TQW40, ,
SPAT
0.3
7.5
18
623
P17
ICPC
Tobacco abuse
4.3
7.5
19
45
SPAT1043
SPAT
Audiometry
0.5
7.4
75
1401
C09CA01
ATC
losartan; oral
0.7
7.4
260
3587
I50.0
ICD-10 Finland
Congestive heart failure
0.6
7.3
114
1881
GBA22
NOMESCO Finland
Endoscopic excision of lesion of trachea
+∞
7.3
7
*
R31
ICD-10 Finland
Unspecified haematuria
0.6
7.3
136
2145
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.7
7.3
196
2849
-1, ,
NOMESCO Finland
0.7
7.2
195
2832
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
0.3
7.2
26
727
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.8
7.2
102
576
UGC02
NOMESCO Finland
Rigid bronchoscopy
7.3
7.2
16
22
L03AA02
ATC
filgrastim; parenteral
2.3
7.2
53
236
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
4.5
7.2
17
38
114
Kela drug reimbursment
Glaucoma
0.6
7.2
90
1575
M01AC06
ATC
meloxicam; systemic, rectal
0.7
7.2
309
4112
C09AA02
ATC
enalapril; systemic
0.7
7.1
281
3800
H61.2
ICD-10 Finland
Impacted cerumen
0.4
7.1
27
737
J01CA08
ATC
pivmecillinam; oral
0.6
7.1
179
2638
Z71.8
ICD-10 Finland
Other specified counselling
0.7
7.0
197
2842
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
4.2
7.0
18
43
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
0.4
7.0
36
858
R03AC13
ATC
formoterol; inhalant
1.8
7.0
102
582
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.7
6.9
434
5450
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.4
6.8
27
722
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
2.4
6.8
44
185
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.4
6.8
393
3032
1440
FHL
Mediastinoscopy
9.3
6.8
13
14
7863A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Haemoptysis
3.6
6.8
21
58
OAB42, ,
SPAT
0.4
6.7
29
745
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.7
6.7
173
2538
KED22
NOMESCO Finland
Transurethral resection of prostate
0.6
6.7
96
1619
R42
ICD-10 Finland
Dizziness and giddiness
0.7
6.7
236
3256
L02AE02
ATC
leuprorelin; implant, parenteral
0.5
6.6
56
1110
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
7.8
6.6
14
18
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
5.9
6.6
17
29
C09CA06
ATC
candesartan; oral
0.7
6.6
169
2484
R33
ICD-10 Finland
Retention of urine
0.6
6.6
125
1964
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.9
6.6
85
467
S01ED51
ATC
timolol, combinations; ophthalmic
0.5
6.5
65
1221
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.0
6.5
70
361
J01DB01
ATC
cefalexin; oral
0.8
6.5
1072
11928
Z57.2
ICD-10 Finland
Occupational exposure to dust
5.3
6.5
18
34
H02AB07
ATC
prednisone; oral
1.4
6.5
270
1971
WX320
NOMESCO Finland
Spinalanesthesy
0.7
6.4
231
3180
A04AA03
ATC
tropisetron; systemic
7.4
6.4
14
19
WX734
NOMESCO Finland
JET-ventilation
14.3
6.4
10
7
WZC30, ,
SPAT
0.2
6.3
10
441
D01BA02
ATC
terbinafine; oral
0.7
6.3
236
3227
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
2.1
6.3
58
283
1625X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,EI HIST/SYTOL DG]
11.1
6.3
11
10
B01AF01
ATC
rivaroxaban; oral
0.6
6.3
100
1641
Z96.1
ICD-10 Finland
Presence of intraocular lens
0.7
6.2
176
2537
UDQ22
NOMESCO Finland
Microlaryngoscopy
3.2
6.1
23
72
R03BB07
ATC
umeclidinium bromide; inhalant
3.4
6.1
21
62
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
0.6
6.1
130
1992
SPAT1310
SPAT
Counselling related to known health issue
0.7
6.1
278
3679
5010A
ICD-9 Finland
Asbestosis[ASBESTOSIS]
7.7
6.1
13
17
GD6AD
NOMESCO Finland
CT of chest and neck
7.7
6.1
13
17
WX290
NOMESCO Finland
Other blockage of nerve
0.7
6.1
270
3589
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.7
6.1
161
2353
C34.95
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other non-microcellular carcinoma
12.6
6.1
10
8
R02AD02
ATC
lidocaine; local oral
3.0
6.1
25
83
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
6.1
40
170
N05BA02
ATC
chlordiazepoxide; systemic
2.2
6.1
46
208
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
0.3
6.1
17
537
S29
ICPC
Skin symptom/complaint other
0.6
6.0
130
1986
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
6.0
384
3001
WW500
NOMESCO Finland
Blood transfusion
1.9
6.0
76
415
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
336
221
17.98
307.65
1.2
1.1
—
—
—
0
0
278
391
8.07
191.60
1.3
1.5
—
—
—
0
0
295
655
5.09
126.55
2.1
2.6
—
—
—
0
0
147
284
5.50
72.94
1.3
1.3
—
—
—
0
0
773
11769
0.45
64.64
6.1
6.7
42.44
41.50
mmol/mol
1.75
678
10555
834
12189
0.47
59.46
4.2
5.4
2.46
2.45
mmol/l
0.07
710
10841
796
11799
0.47
58.56
3.8
4.8
4.24
4.26
mmol/l
0.16
687
10556
783
11650
0.47
57.82
3.8
4.7
1.31
1.37
mmol/l
3.09
665
10317
278
1042
2.93
53.73
6.5
2.0
427.00
376.64
nmol/l
3.18
269
933
767
11281
0.49
51.48
3.5
4.3
1.33
1.26
mmol/l
1.91
645
9912
870
12173
0.51
48.62
5.5
5.1
6.20
6.18
mmol/l
0.24
761
10676
1033
13613
0.51
46.53
43.6
27.5
38.08
39.07
%
6.01
954
12364
1034
13620
0.52
46.47
43.1
27.4
8.43
7.10
e9/l
25.21
1002
13017
1034
13619
0.52
46.44
43.3
27.6
125.30
132.34
g/l
36.87
1013
13225
1034
13618
0.52
46.41
43.1
27.4
4.23
4.37
e12/l
13.91
999
13014
1034
13614
0.52
46.29
43.2
27.4
277.86
230.31
e9/l
50.55
1004
13079
506
8410
0.47
46.26
4.2
5.5
2.43
4.81
ug/l
4.01
426
7330
366
1723
2.37
43.98
2.6
3.8
7.86
29.20
ug/l
2.57
334
1454
91
182
5.19
43.27
1.3
1.3
14.49
8.64
u/l
2.98
76
145
1033
13444
0.53
41.58
32.0
22.8
4.04
4.03
mmol/l
0.44
1010
12957
1033
13427
0.54
41.10
32.3
22.6
138.44
139.58
mmol/l
29.96
1011
12963
463
2479
2.12
40.29
4.0
2.9
0.78
0.82
mmol/l
12.52
449
2289
1012
13196
0.54
40.05
35.5
22.4
81.19
91.96
umol/l
22.24
1012
13189
1012
13144
0.55
38.64
18.3
11.1
22.22
25.18
u/l
3.95
995
12438
388
6773
0.47
38.23
3.9
4.8
21.57
22.13
%
0.31
183
3602
823
11159
0.56
34.17
5.9
4.3
1.99
2.10
mu/l
0.83
742
9777
68
133
5.25
33.15
1.3
1.3
—
—
—
0
0
885
11649
0.58
31.54
28.5
18.1
77.36
69.93
ml/min/173m2
25.01
792
9712
245
4778
0.45
31.16
2.8
3.3
0.75
0.85
ug/l
1.40
165
3427
402
6531
0.52
29.53
1.8
2.2
85.50
90.59
pmol/l
1.55
235
3549
366
2066
1.94
26.38
4.4
3.8
223.63
248.42
u/l
3.54
356
1917
106
351
3.13
25.13
1.4
1.5
36.79
30.05
g/l
7.86
98
313
787
10332
0.61
24.32
36.1
22.2
15.21
15.56
%
1.80
773
10060
1031
12707
0.62
24.18
32.6
19.0
42.54
30.00
mg/l
22.04
996
10599
134
3038
0.40
23.93
1.6
1.6
1.44
1.30
mmol/l
1.55
115
2466
93
305
3.15
22.41
1.4
1.5
1576.57
1980.24
e6/l
0.43
70
217
88
280
3.24
22.30
1.4
1.4
17590.34
60561.11
e6/l
1.95
56
167
68
205
3.40
18.81
2.8
3.6
—
—
—
0
0
327
5072
0.58
18.11
1.8
2.1
74.68
78.08
nmol/l
1.29
284
4327
28
17
16.69
17.86
1.0
1.1
—
—
—
0
0
62
185
3.42
17.44
1.2
1.3
9.52
15.44
u/l
1.66
62
172
36
74
4.93
16.64
1.2
1.2
17.45
25.46
iu/l
0.88
26
63
56
169
3.38
15.50
1.4
1.4
11.59
14.19
u/l
2.68
56
157
243
3940
0.57
15.44
1.4
1.6
18.47
19.23
nmol/l
0.35
207
3342
162
833
2.03
14.95
2.1
1.8
1.25
2.87
ug/l
1.19
145
717
372
5380
0.62
14.87
2.4
2.9
247.61
178.17
ug/l
2.92
337
4788
472
6445
0.65
14.38
3.9
4.0
0.00
0.00
estimate
-0.00
107
1178
325
4817
0.61
14.33
3.6
3.8
13.02
10.23
mg/mmol
0.42
207
3192
693
8770
0.68
14.29
5.0
3.4
15.36
15.12
pmol/l
1.41
632
7627
301
4535
0.61
14.19
3.0
3.2
7.26
7.52
mmol/l
0.47
230
3700
300
4515
0.61
14.05
3.1
3.3
385.93
245.06
mg/l
0.28
203
3051
470
6382
0.66
13.77
3.9
4.0
0.00
0.00
estimate
0.88
114
1328
467
6336
0.66
13.58
5.2
5.3
0.00
0.00
estimate
-0.00
113
1215
786
6262
1.41
12.32
7.5
5.8
20.82
24.81
%
21.39
763
5791
82
349
2.41
12.09
1.3
1.7
—
—
—
0
0
86
375
2.35
12.02
1.3
1.6
—
—
—
0
0
34
87
3.96
12.01
1.3
1.6
1.46
2.35
%
0.33
28
72
170
966
1.83
11.63
6.0
6.9
25.79
24.54
mmol/l
4.64
170
954
222
3449
0.60
11.52
1.7
1.8
441.96
19111687.01
pmol/l
1.90
188
2768
352
4929
0.66
11.52
4.3
4.3
—
—
—
0
0
308
2064
1.58
11.39
6.9
6.5
1.88
1.09
mmol/l
3.44
262
1572
308
2064
1.58
11.39
6.9
6.5
5.43
5.05
kpa
5.58
296
1938
308
2064
1.58
11.39
6.9
6.5
10.49
11.50
kpa
4.62
296
1942
263
3910
0.62
11.31
2.7
3.0
2168.99
7180.89
umol/l
1.88
212
3290
764
6157
1.38
10.81
7.2
5.6
63.55
59.48
%
16.16
742
5703
61
239
2.60
10.73
1.3
1.6
—
—
—
0
0
61
239
2.60
10.73
1.3
1.6
—
—
—
0
0
900
7469
1.36
10.52
15.0
8.3
5.30
4.50
e9/l
11.44
814
6447
404
2922
1.48
10.40
2.0
1.9
—
—
—
0
0
278
1858
1.57
10.36
7.2
6.7
94.37
95.01
%
0.76
270
1777
65
268
2.47
10.31
1.3
1.7
—
—
—
0
0
51
187
2.77
10.22
1.5
1.6
2.43
5.38
iu/l
2.21
12
52
45
156
2.93
9.99
1.3
1.5
—
—
—
0
0
45
156
2.93
9.99
1.3
1.5
—
—
—
0
0
42
142
3.00
9.75
1.1
1.7
—
—
—
0
0
115
612
1.93
9.66
1.8
2.1
194.00
702.86
ug/l
3.02
106
579
58
238
2.48
9.32
3.1
3.0
5.93
4.63
e9/l
2.83
58
238
786
9326
0.75
9.19
4.4
4.9
139.10
2322.04
e6/l
2.20
20
205
245
1635
1.57
9.15
7.8
7.3
120.28
120.48
g/l
0.06
239
1594
261
3720
0.66
8.97
1.7
1.8
1025.59
1149.59
nmol/l
1.50
199
2737
42
150
2.84
8.87
1.1
1.7
—
—
—
0
0
54
221
2.48
8.74
1.3
1.6
—
—
—
0
0
170
1051
1.67
8.67
1.6
1.5
—
—
—
0
0
317
4321
0.69
8.62
2.0
2.3
3.41
3.15
mg/l
0.76
272
3600
58
249
2.37
8.48
3.5
3.4
65.57
59.94
%
2.65
58
249
39
140
2.82
8.18
1.3
1.7
284.03
287.02
mu/l
0.04
39
131
120
2006
0.57
8.10
1.2
1.2
2.04
1.68
u/ml
0.14
29
491
32
104
3.11
7.99
1.3
1.6
64.89
69.94
%
0.35
27
80
32
108
2.99
7.51
2.9
3.5
—
—
—
0
0
610
7313
0.76
6.99
4.6
3.2
65.36
60.66
u/l
0.32
571
6583
341
2564
1.40
6.90
1.9
1.9
29.77
30.46
s
1.75
336
2475
275
1996
1.44
6.79
1.9
1.9
—
—
—
0
0
203
2887
0.67
6.73
4.4
4.4
1.02
1.02
kg/l
0.45
32
465
55
256
2.18
6.72
1.5
1.4
—
—
—
0
0
269
3622
0.70
6.61
4.2
4.3
0.02
0.00
estimate
0.41
93
1109
274
2003
1.42
6.50
1.9
1.8
—
—
—
0
0
805
6900
1.27
6.42
7.8
6.1
1.22
1.20
mmol/l
8.98
770
6196
50
230
2.20
6.31
1.5
1.4
—
—
—
0
0
119
1865
0.62
6.19
1.4
1.5
3.20
2.93
g/l
0.52
67
1069
35
141
2.51
5.95
1.1
1.6
—
—
—
0
0
35
141
2.51
5.95
1.1
1.6
—
—
—
0
0
35
141
2.51
5.95
1.1
1.6
—
—
—
0
0
377
2954
1.34
5.82
5.5
3.1
2.54
2.45
mmol/l
21.38
347
2526
858
7484
1.25
5.70
10.5
6.0
9.33
13.10
umol/l
14.99
839
7062
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
116
730
1.62
5.59
2.2
2.5
0.26
0.34
u/ml
2.92
65
411
116
1779
0.63
5.49
3.6
4.8
33.27
33.09
%
0.06
78
1161
16
43
3.74
5.37
1.4
1.8
2.22
3.95
%
—
9
21
45
213
2.14
5.34
1.4
1.5
—
—
—
0
0
125
1860
0.65
5.15
14.5
9.2
—
—
—
0
0
211
1539
1.41
5.07
5.5
6.2
1.31
1.49
mmol/l
2.01
206
1484
858
7563
1.23
4.97
8.4
7.0
1.22
1.21
mmol/l
7.77
744
6335
43
207
2.10
4.91
1.4
1.5
—
—
—
0
0
170
1199
1.46
4.90
4.0
3.8
5.45
5.14
kpa
2.99
164
1128
39
181
2.18
4.89
1.3
1.7
—
—
—
0
0
28
112
2.52
4.88
1.1
1.6
—
—
—
0
0
478
3953
1.27
4.87
4.6
3.0
28.60
35.36
u/l
3.79
465
3737
162
1136
1.46
4.82
3.9
3.7
2.51
1.91
mmol/l
1.27
136
817
854
9562
0.82
4.75
5.7
4.1
25.70
15.16
mm/h
30.97
814
8644
430
3523
1.28
4.71
2.5
2.6
—
—
—
0
0
462
5457
0.80
4.16
2.6
2.2
—
—
—
0
0
6
228
0.26
3.89
1.0
1.1
—
14.49
—
0
12
73
451
1.64
3.88
2.6
3.1
7.50
7.63
kpa
0.35
73
440
67
407
1.67
3.80
5.5
5.0
5.20
4.98
kpa
1.03
67
396
33
160
2.08
3.77
1.1
1.5
—
—
—
0
0
74
1147
0.63
3.73
2.0
2.1
10.60
11.69
nmol/l
0.58
64
972
67
410
1.66
3.71
2.0
2.3
121.42
126.82
g/l
0.84
40
294
426
3580
1.24
3.69
4.9
4.1
87.89
80.09
%
8.92
421
3476
33
162
2.05
3.66
1.1
1.5
—
—
—
0
0
33
163
2.04
3.60
1.1
1.5
—
—
—
0
0
32
162
1.99
3.30
1.1
1.5
—
—
—
0
0
17
397
0.42
3.29
1.4
1.8
—
—
—
0
0
150
1116
1.37
3.27
1.7
1.7
—
—
—
0
0
32
163
1.98
3.24
1.1
1.5
—
—
—
0
0
32
163
1.98
3.24
1.1
1.5
—
—
—
0
0
185
2365
0.76
3.15
2.0
2.7
17.21
22.07
%
5.48
155
1983
195
2467
0.77
3.07
1.9
2.6
2.15
2.20
g/l
0.53
183
2242
65
419
1.57
2.98
1.2
1.4
—
—
—
0
0
65
419
1.57
2.98
1.2
1.4
—
—
—
0
0
554
6256
0.84
2.95
4.8
4.4
46.64
98.23
ng/l
1.10
471
5011
99
700
1.44
2.92
2.0
1.8
—
—
—
0
0
19
82
2.33
2.91
1.5
1.8
—
—
—
0
0
21
95
2.22
2.90
1.7
1.6
—
—
—
0
0
149
1133
1.34
2.86
10.7
6.4
25.82
24.37
mmol/l
4.19
143
1080
73
490
1.51
2.81
1.4
1.7
—
—
—
0
0
552
4874
1.18
2.79
5.2
3.2
2.38
2.33
mmol/l
9.64
515
4144
77
524
1.49
2.78
3.0
3.4
25.97
24.89
mmol/l
1.47
77
514
106
769
1.40
2.73
2.1
1.9
—
—
—
0
0
216
2654
0.79
2.69
1.9
2.6
9.16
11.98
umol/l
8.70
205
2426
876
8048
1.15
2.63
14.2
21.0
1.30
1.45
inr
4.17
222
2242
21
100
2.11
2.59
3.2
3.3
—
—
—
0
0
115
1524
0.74
2.55
1.2
1.2
23.64
15.86
u/ml
0.28
25
509
20
94
2.14
2.55
1.7
1.6
—
—
—
0
0
66
959
0.68
2.52
1.4
1.7
1.95
1.54
g/l
2.70
55
803
23
115
2.01
2.51
1.7
1.5
—
—
—
0
0
502
4436
1.17
2.49
5.0
2.5
55.99
79.35
u/l
0.70
482
4076
95
697
1.38
2.33
4.9
4.1
25.70
24.79
mmol/l
2.07
90
638
26
140
1.87
2.32
1.5
1.7
—
—
—
0
0
76
537
1.43
2.31
7.1
3.9
4.00
3.99
mmol/l
0.12
76
529
9
216
0.41
2.31
1.0
1.1
—
—
—
0
0
10
34
2.95
2.28
1.2
1.2
—
—
—
0
0
14
60
2.34
2.22
1.5
1.2
30.14
22.00
%
0.44
14
44
9
30
3.01
2.14
1.2
2.5
—
—
—
0
0
16
74
2.17
2.14
1.0
1.5
—
—
—
0
0
16
74
2.17
2.14
1.0
1.5
—
—
—
0
0
516
5735
0.87
2.13
3.3
3.5
—
—
—
0
0
57
390
1.47
2.08
2.9
2.8
14.44
15.62
%
1.22
32
197
136
1706
0.78
2.05
1.8
2.5
73.52
66.81
e9/l
1.21
99
1331
49
721
0.67
2.05
1.8
2.4
8.45
7.40
g/l
3.40
42
634
49
720
0.67
2.04
1.8
2.4
4.79
3.71
g/l
0.95
42
632
49
720
0.67
2.04
1.8
2.4
—
—
—
0
0
20
104
1.93
2.00
1.1
1.4
—
—
—
0
0
994
10550
0.89
1.96
14.3
7.6
85.46
83.42
u/l
0.60
973
9802
38
241
1.59
1.96
8.7
8.2
7.40
7.43
mmol/l
0.02
31
199
20
361
0.55
1.96
1.1
1.0
—
—
—
0
0
20
105
1.91
1.95
1.1
1.4
—
—
—
0
0
15
296
0.50
1.95
1.5
1.2
587.67
588.88
mg/l
0.00
15
277
713
6569
1.13
1.91
5.8
4.8
31.98
33.97
g/l
14.58
682
5997
40
600
0.66
1.86
2.0
2.6
3.03
1.29
g/l
0.59
32
501
76
1017
0.74
1.86
1.8
2.2
195.71
173.49
ug/g
0.15
60
807
42
623
0.67
1.86
1.5
3.2
—
1.99
—
0
49
86
650
1.34
1.81
6.4
3.7
1.30
1.45
mmol/l
0.92
86
638
31
488
0.63
1.81
1.4
1.5
—
—
—
0
0
13
60
2.17
1.77
2.3
2.5
—
—
—
0
0
13
60
2.17
1.77
2.3
2.5
—
—
—
0
0
11
48
2.30
1.70
1.0
1.4
—
—
—
0
0
46
656
0.69
1.68
1.9
2.4
3.44
3.01
g/l
1.96
39
570
133
1628
0.80
1.66
1.2
1.2
64.37
39.69
iu/ml
0.51
30
514
48
677
0.70
1.65
1.8
2.4
10.80
10.67
g/l
0.05
40
588
92
1175
0.77
1.65
2.7
4.0
67.45
102.82
ng/l
5.30
76
993
45
637
0.70
1.59
1.5
3.2
68.32
70.82
mg/l
0.06
31
508
45
637
0.70
1.59
1.5
3.2
34.01
76.13
mg/l
1.23
31
513
16
85
1.89
1.55
1.3
1.6
—
—
—
0
0
16
85
1.89
1.55
1.3
1.6
—
—
—
0
0
17
297
0.57
1.54
1.7
1.5
—
—
—
0
0
13
243
0.53
1.49
1.2
1.3
—
—
—
0
0
14
255
0.55
1.47
1.4
1.2
3.93
3.96
mmol/l
0.07
14
231
38
544
0.69
1.45
1.5
1.4
—
—
—
0
0
68
516
1.33
1.45
5.2
3.2
4.39
4.28
pmol/l
0.34
62
441
6
22
2.73
1.43
8.8
15.8
2301.83
1491.59
nmol/l
—
6
22
39
553
0.70
1.42
1.8
2.4
36.21
36.84
g/l
0.27
32
468
9
41
2.20
1.37
1.2
1.8
—
—
—
0
0
199
2297
0.85
1.37
2.3
2.3
1.80
1.75
%
0.27
173
1999
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
10
195
0.51
1.33
1.1
1.2
—
—
—
0
0
0
40
0.00
1.32
0.0
1.2
—
—
—
0
0
61
463
1.33
1.32
1.2
1.1
52.11
147.21
iu/ml
2.14
12
153
37
521
0.70
1.31
1.9
2.4
0.02
0.03
g/l
0.40
31
467
5
18
2.78
1.28
1.2
1.1
—
—
—
0
0
510
5513
0.90
1.28
3.0
3.3
1423.47
2281.11
ng/l
8.92
468
4774
15
253
0.59
1.24
1.2
1.3
—
—
—
0
0
21
324
0.64
1.20
1.5
1.3
1.15
1.14
g/l
0.06
21
310
24
359
0.66
1.19
1.0
1.5
206.86
258.50
ug/g
0.75
14
229
78
970
0.80
1.19
1.7
1.6
1.91
1.67
%
0.96
59
781
14
237
0.59
1.18
1.2
1.3
—
—
—
0
0
12
65
1.85
1.13
1.3
2.4
—
—
—
0
0
27
386
0.70
1.08
1.4
1.3
—
—
—
0
0
21
313
0.67
1.05
1.4
1.3
0.21
0.24
g/l
0.56
21
299
14
228
0.61
1.04
2.6
1.6
—
—
—
0
0
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
187
1649
1.15
1.01
3.6
6.7
8.99
12.18
mmol/l
7.08
176
1539
453
4870
0.91
1.01
3.3
3.6
99.66
112.53
e6/l
0.12
372
3912
140
1616
0.86
1.01
2.1
2.7
6.69
11.29
umol/l
2.16
122
1424
0
31
0.00
0.96
0.0
1.0
—
1488.16
—
0
31
36
479
0.75
0.96
1.9
2.5
0.00
0.00
g/l
-0.00
31
433
40
302
1.33
0.95
1.3
1.6
—
—
—
0
0
37
488
0.75
0.93
1.9
2.5
0.00
0.00
g/l
-0.00
31
435
9
152
0.59
0.88
1.0
1.0
—
—
—
0
0
241
2654
0.90
0.88
3.0
3.0
0.93
1.09
e6/l
0.41
140
1623
12
193
0.62
0.87
1.9
2.2
3.15
231.90
u/ml
0.58
12
188
33
246
1.35
0.87
2.2
2.0
86.75
88.81
%
0.54
33
246
145
1274
1.15
0.86
4.3
4.0
1.24
1.22
mmol/l
3.25
136
1098
18
263
0.68
0.85
1.1
1.3
1.79
0.82
nmol/l
0.61
12
211
136
1193
1.15
0.83
1.5
1.6
—
—
—
0
0
33
432
0.76
0.82
4.3
3.7
1.73
1.66
mmol/l
0.09
33
424
148
1670
0.88
0.81
2.9
3.1
167.75
302.81
ng/l
7.68
139
1533
8
47
1.70
0.80
1.1
1.1
1.42
1.41
mmol/l
—
8
34
10
58
1.73
0.79
1.1
1.6
—
—
—
0
0
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
151
1695
0.88
0.77
4.9
3.9
—
—
—
0
0
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
49
605
0.81
0.77
2.0
3.1
25.18
7222.97
u/ml
0.92
39
510
32
416
0.77
0.76
1.2
1.2
—
—
—
0
0
6
34
1.77
0.76
3.5
1.7
—
—
—
0
0
27
200
1.35
0.76
1.3
2.4
—
1712.77
u/ml
—
0
22
10
59
1.70
0.75
1.2
1.8
—
—
—
0
0
10
59
1.70
0.75
1.2
1.8
—
—
—
0
0
322
3465
0.92
0.75
2.5
2.8
5.91
3.74
e6/l
1.79
293
3124
36
280
1.29
0.74
1.2
1.4
—
—
—
0
0
7
40
1.75
0.71
1.1
1.1
0.78
1.03
mmol/l
—
7
30
7
40
1.75
0.71
1.1
1.2
—
—
—
0
0
38
300
1.27
0.71
2.3
2.0
1.66
1.74
mmol/l
0.31
38
294
10
158
0.63
0.70
1.7
1.6
—
—
—
0
0
27
354
0.76
0.70
1.2
1.2
—
—
—
0
0
33
257
1.29
0.68
2.8
5.2
282.00
896.24
iu/ml
—
5
37
27
352
0.76
0.68
1.2
1.2
—
—
—
0
0
20
144
1.39
0.68
1.4
1.4
280.67
277.96
mosm/kgh2o
0.24
15
102
10
62
1.62
0.65
1.2
1.7
—
—
—
0
0
27
347
0.78
0.62
1.5
1.6
79819.90
18699.02
e6/l
0.60
20
247
6
101
0.59
0.62
2.0
1.3
—
—
—
0
0
32
402
0.79
0.62
4.3
3.9
6.88
7.78
mmol/l
2.52
32
394
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
239
2571
0.92
0.58
3.1
3.3
3.01
1.30
e6/l
1.07
138
1549
5
87
0.57
0.56
2.0
2.2
—
—
—
0
0
11
73
1.51
0.56
2.7
3.0
189.45
214.03
u/l
0.68
11
73
333
3139
1.07
0.55
5.2
4.2
245.69
442.05
ng/l
0.62
296
2793
110
988
1.12
0.53
1.3
1.2
—
—
—
0
0
10
67
1.49
0.49
1.6
1.2
—
—
—
0
0
7
107
0.65
0.48
1.0
1.1
124.00
110.37
%
—
7
98
168
1552
1.09
0.48
1.7
2.5
65.80
65.86
g/l
0.03
153
1391
7
111
0.63
0.48
1.0
1.1
—
—
—
0
0
5
83
0.60
0.45
1.0
1.2
—
—
—
0
0
37
439
0.84
0.45
2.1
2.3
84.58
89.76
ug/min
0.05
18
259
10
141
0.71
0.44
1.0
1.3
324.00
254.92
pmol/l
—
5
119
11
78
1.41
0.43
1.2
1.1
125.55
114.07
u/l
0.08
11
67
13
173
0.75
0.42
1.3
1.7
4.34
4.34
mmol/24h
0.00
13
150
0
15
0.00
0.41
0.0
1.3
—
16.60
—
0
15
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
2.6
—
97.79
—
0
16
0
16
0.00
0.41
0.0
1.6
—
14.40
—
0
10
130
1408
0.92
0.41
3.2
3.0
4.58
4.41
kpa
0.30
123
1339
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
40
343
1.17
0.40
1.5
1.5
3.35
16.96
iu/ml
—
9
83
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
418
4344
0.95
0.38
3.2
3.5
0.68
0.51
e6/l
0.65
337
3454
33
388
0.85
0.38
4.2
3.8
49.15
31.45
mg/l
1.31
26
262
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
8
115
0.69
0.37
1.3
1.2
—
—
—
0
0
17
213
0.80
0.36
1.3
1.2
—
—
—
0
0
447
4627
0.96
0.35
2.2
2.2
160.39
259.56
u/l
2.49
423
4296
119
1103
1.08
0.35
5.3
3.0
64.10
58.25
ml/min/173m2
1.11
52
486
13
167
0.78
0.34
1.4
1.9
2.17
2.10
u/field
—
6
59
78
856
0.91
0.34
4.6
4.2
48.13
46.96
%
0.17
78
843
19
232
0.82
0.33
2.9
2.3
36.13
21.63
mg/l
—
8
49
7
53
1.32
0.30
1.3
1.7
12.43
15.56
nmol/l
—
7
47
158
1670
0.94
0.29
2.2
2.5
5.95
6.69
ug/l
0.21
140
1418
280
2695
1.05
0.27
1.5
1.7
1.26
1.63
mg/l
1.85
237
2134
19
225
0.84
0.26
1.0
1.1
—
—
—
0
0
10
77
1.30
0.26
1.0
1.3
—
—
—
0
0
20
169
1.19
0.26
2.4
2.7
—
—
—
0
0
11
138
0.80
0.25
1.0
1.1
—
—
—
0
0
10
78
1.28
0.24
2.0
2.8
40.20
36.74
%
—
5
47
6
84
0.71
0.24
1.0
1.1
95.33
96.01
%
—
6
78
5
38
1.32
0.23
1.2
1.0
—
—
—
0
0
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
5.1
—
—
—
0
0
0
12
0.00
0.21
0.0
5.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
45
489
0.92
0.19
1.2
1.7
36.40
38.20
u/l
0.26
38
409
12
142
0.84
0.17
1.2
1.4
—
—
—
0
0
5
66
0.76
0.17
1.0
1.1
—
—
—
0
0
5
69
0.72
0.17
1.2
1.2
—
—
—
0
0
5
70
0.71
0.16
1.4
1.1
95.20
99.13
u/l
—
5
63
5
70
0.71
0.16
1.4
1.1
11.60
33.39
u/l
—
5
64
15
173
0.87
0.16
1.2
1.4
73.78
65.77
%
—
9
112
6
76
0.79
0.15
1.3
1.0
—
—
—
0
0
858
8674
0.98
0.15
7.1
5.0
6.88
6.97
mmol/l
0.65
839
8200
31
338
0.92
0.15
1.4
2.1
88.94
85.66
%
0.26
31
325
7
89
0.79
0.14
1.0
1.1
—
—
—
0
0
166
1712
0.97
0.14
3.1
3.7
6.08
5.83
kpa
2.02
161
1639
29
315
0.92
0.13
1.7
1.7
—
—
—
0
0
11
127
0.87
0.12
1.7
1.3
—
—
—
0
0
24
262
0.92
0.12
2.9
2.9
4.15
4.11
mmol/l
0.20
24
257
24
262
0.92
0.12
2.9
2.9
105.54
105.67
mmol/l
0.05
24
257
12
136
0.88
0.11
1.0
1.3
—
0.46
nmol/l
—
0
8
12
135
0.89
0.09
1.3
1.3
14.62
22.99
%
—
5
88
10
114
0.88
0.09
1.0
1.1
—
—
—
0
0
167
1705
0.98
0.09
3.1
3.7
2.69
1.97
mmol/l
1.77
147
1366
6
58
1.03
0.08
1.0
1.2
—
—
—
0
0
5
65
0.77
0.08
1.2
1.4
—
—
—
0
0
7
68
1.03
0.07
1.3
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
9
87
1.03
0.07
1.4
2.1
—
—
—
0
0
47
455
1.03
0.05
2.8
3.0
0.80
0.85
nmol/l
0.45
40
344
27
258
1.05
0.04
1.3
1.2
3.70
2.83
u/ml
—
10
34
23
220
1.05
0.03
1.3
1.2
13.67
7.35
u/ml
—
6
15
91
924
0.98
0.03
3.8
3.5
26.90
24.90
mmol/l
5.41
91
896
220
2217
0.99
0.03
4.8
5.6
0.98
1.03
mmol/l
2.50
208
2020
641
6394
1.00
0.02
2.9
2.8
—
—
—
0
0
142
1409
1.01
0.02
1.7
2.1
0.20
0.19
g/l
0.19
132
1291
56
551
1.02
0.02
1.1
1.2
—
—
—
0
0
21
216
0.97
0.00
1.2
1.4
—
—
—
0
0
126
1255
1.00
0.00
2.9
2.4
36.05
36.64
u/l
0.03
111
1040
26
256
1.02
0.00
1.3
1.2
1.80
4.16
u/ml
—
5
22
11
107
1.03
0.00
1.2
1.2
8.79
7.68
mmol/l
0.31
11
87
0
8
0.00
0.00
0.0
1.1
—
31.32
—
0
8
0
8
0.00
0.00
0.0
1.3
—
85.88
—
0
8
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
18.75
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
10
100
1.00
-0.00
2.1
2.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
93
0.97
-0.00
1.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.0
—
382.00
—
0
5
0
5
0.00
-0.00
0.0
8.0
—
74.80
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
2.20
—
0
5
5
49
1.02
-0.00
1.0
1.2
117.00
234.12
iu/ml
—
5
49
5
59
0.85
-0.00
1.0
1.4
5.36
9.04
u/l
—
5
47
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: HLP_C3_NSCLC_SQUAM – Non-small cell lung cancer, squamous, helper endpoint
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).